Changing Pattern of Plasmodium falciparum

Antimalarials / pharmacology Artemether / therapeutic use Artemether, Lumefantrine Drug Combination Artemisinins / pharmacology Drug Resistance / genetics Humans Malaria, Falciparum / drug therapy Multidrug Resistance-Associated Proteins / genetics Plasmodium falciparum / genetics Polymorphism, Genetic / genetics Rwanda
Plasmodium falciparum Rwanda malaria multidrug resistance

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 08 2021
Historique:
pubmed: 7 7 2021
medline: 25 8 2021
entrez: 6 7 2021
Statut: ppublish

Résumé

Plasmodium falciparum

Identifiants

DOI: 10.1128/AAC.00901-21 PMID: 34228534 PMC: PMC8370211
pubmed: 34228534
doi: 10.1128/AAC.00901-21
pmc: PMC8370211
doi:

Substances chimiques

Antimalarials 0
Artemether, Lumefantrine Drug Combination 0
Artemisinins 0
Mdr1 protein, Plasmodium falciparum 0
Multidrug Resistance-Associated Proteins 0
Artemether C7D6T3H22J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0090121

Références

Trans R Soc Trop Med Hyg. 2018 Nov 01;112(11):513-521
pubmed: 30184186
Trop Dis Travel Med Vaccines. 2016 Jul 7;2:10
pubmed: 28883954
Nat Med. 2020 Oct;26(10):1602-1608
pubmed: 32747827
Open Forum Infect Dis. 2016 Oct 25;4(1):ofw229
pubmed: 28480232
Pathog Glob Health. 2014 Oct;108(7):339-43
pubmed: 25348116
BMJ Glob Health. 2018 Oct 19;3(5):e000999
pubmed: 30397515
J Infect Dis. 2014 Jul 1;210(1):154-7
pubmed: 24446524
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73
pubmed: 19770282
J Infect Dis. 2013 Mar 1;207(5):842-7
pubmed: 23225895
N Engl J Med. 2006 Nov 9;355(19):1959-66
pubmed: 17093247
Am J Trop Med Hyg. 2014 Oct;91(4):833-843
pubmed: 25048375
Acta Trop. 2012 Jan;121(1):50-4
pubmed: 21996622
Antimicrob Agents Chemother. 2015;59(6):3018-30
pubmed: 25753626
Mol Biochem Parasitol. 1993 Oct;61(2):315-20
pubmed: 8264734
Lancet Infect Dis. 2021 Aug;21(8):1120-1128
pubmed: 33864801
Nat Commun. 2016 May 18;7:11553
pubmed: 27189525
Emerg Infect Dis. 2021 Jan;27(1):294-296
pubmed: 33350925
Malar J. 2014 Mar 17;13:102
pubmed: 24636676

Auteurs

Welmoed van Loon (W)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Clara Bergmann (C)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Felix Habarugira (F)

University Teaching Hospital of Butare, Huye, Rwanda.

Costanza Tacoli (C)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Darius Savelsberg (D)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Rafael Oliveira (R)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Djibril Mbarushimana (D)

University Teaching Hospital of Butare, Huye, Rwanda.

Jules Ndoli (J)

University Teaching Hospital of Butare, Huye, Rwanda.

Augustin Sendegeya (A)

University Teaching Hospital of Butare, Huye, Rwanda.

Claude Bayingana (C)

University of Rwanda, Kigali, Rwanda.

Frank P Mockenhaupt (FP)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Tropical Medicine and International Health, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiparasitaires › Antiprotozoaires › Antipaludiques › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Terpènes › Sesquiterpènes › Artémisinines › Artéméther › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Préparations pharmaceutiques › Association médicamenteuse › Association d'artéméther et de luméfantrine › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Terpènes › Sesquiterpènes › Artémisinines › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Infection › Maladies vectorielles › Paludisme › Paludisme à Plasmodium falciparum › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Pompes ioniques › Transporteurs d'anions › Transporteurs d'anions organiques › Transporteurs d'anions organiques ATP-dépendants › Protéines associées à la multirésistance aux médicaments › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Eucaryotes › Alveolata › Apicomplexa › Haemosporida › Plasmodium › Plasmodium falciparum › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Changing Pattern of Plasmodium falciparum
questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique de l'Est › Rwanda › Changing Pattern of Plasmodium falciparum